BA
AMGN icon

Bristol Advisors’s Amgen AMGN Stock Holding History

Bristol Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-1,400
Closed -$273K – 32
2018
Q4 		$273K Buy
+1,400
New +$273K 0.33% 40
2017
Q4 		– Sell
-1,700
Closed -$317K – 86
2017
Q3 		$317K Buy
+1,700
New +$301K 0.32% 48
2017
Q1 		– Sell
-4,000
Closed -$585K – 52
2016
Q4 		$585K Buy
+4,000
New +$602K 0.59% 33

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bristol Advisors's AMGN Position: Q1 2019 in Review

Bristol Advisors sold out of Amgen (AMGN) in Q1 2019, closing a stake of 1,400 shares — an estimated $273K sold.

Bristol Advisors first reported a position in AMGN in Q4 2016 and held it in 3 quarters. The position peaked at $585K in Q4 2016. 1,886 funds tracked by Wall St. Rank hold AMGN as of Q1 2019.

  • Bristol Advisors reported no remaining Amgen position as of Q1 2019 after selling out during the quarter.
  • Bristol Advisors sold 1,400 Amgen shares in Q1 2019, an estimated $273K.
  • Bristol Advisors first reported a position in Amgen in Q4 2016 and held it in 3 quarters.
  • Bristol Advisors's Amgen position peaked at $585K in Q4 2016.
  • 1,886 funds tracked by Wall St. Rank held Amgen as of Q1 2019.

Based on Bristol Advisors's 13F filing for Q1 2019, filed 29 Apr 2019.